SC 13G/A

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Filing Date
Feb 14, 2018
Document Date
Feb 14, 2018
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM INC